A 9th year follow up study on persitance of Hepatitis A vaccine
Phase 4
- Registration Number
- CTRI/2017/02/007837
- Lead Sponsor
- Wockhardt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
1. Subjects who were enrolled for the Multi-centric Trial on Immunogenecity of single dose of Biovac-ATM Live Attenuated Hepatitis-A Vaccine (MC/Vaccine/2006/CT-01) in 2007 would be considered
2. Subjects who had a baseline anti-HAV antibody titre <20mIU/mL in the initial phase of the study (MC/Vaccine/2006/CT-01).
3. Written informed consent from the parent or guardian of the subjects.
Exclusion Criteria
1. Subjects who had a baseline anti-HAV antibody titre >20mIU/mL(i.e these subjects are considered to be seroprotected prior to vaccination)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method